SARMA S CHALLA

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease BAYTOWN, TX NPI 1699776286

General Payments — all program years on this page

$5,335.98

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 289
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $560.12 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $560.1219

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $613.7936
2019 $970.6659
2020 $538.4031
2021 $837.2747
2022 $1,144.1954
2023 $671.5543
2024 $560.1219

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078193649 Janssen Pharmaceuticals, Inc $16.72 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078193705 Janssen Pharmaceuticals, Inc $27.27 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086727885 Novartis Pharmaceuticals Corporation $24.35 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086727887 Novartis Pharmaceuticals Corporation $21.72 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086727897 Novartis Pharmaceuticals Corporation $16.85 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086727937 Novartis Pharmaceuticals Corporation $22.68 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115489118 Amgen Inc. $22.66 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115489124 Amgen Inc. $15.69 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125204622 Abbott Laboratories $36.81 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129430422 Esperion Therapeutics, Inc. $21.78 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131086262 PFIZER INC. $25.21 02/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131312662 PFIZER INC. $28.54 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131678969 PFIZER INC. $28.71 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132267716 SCPHARMACEUTICALS INC. $17.53 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132919156 ERBE USA INC $160.73 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139655717 SANOFI-AVENTIS U.S. LLC $22.05 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141563335 Merck Sharp & Dohme LLC $13.40 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141824367 Merck Sharp & Dohme LLC $17.27 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141911813 Merck Sharp & Dohme LLC $20.15 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.